带有核心结合因子重组的急性髓性白血病:10年癌症中心经验
Shehab Fareed1, Dina Sameh Soliman2, Abdulrahman F Al-Mashdali1
1Division of Hematology, Department of Medical Oncology, National Center for Cancer Care and Research (NCCCR), Hamad Medical Corporation (HMC), Doha, Qatar.
Oncology
|February 17, 2025
概括
核心结合因子急性髓性白血病 (CBF-AML) 呈现出各种特征. 这项研究建议重新评估预后标志物和优化治疗策略,以便在CBF-AML患者中获得更好的结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 核心结合因子急性髓性白血病 (CBF-AML) 是通过特定的染色体重组来定义的: t(8;21) 或 inv(16) / t(16;16).
- 了解CBF-AML异质性对于有效治疗至关重要.
研究的目的:
- 分析卡塔尔的一组CBF-AML患者的临床病理特征和生存结果.
- 评估各种因素对预后的影响.
主要方法:
- 追溯分析了2013年至2022年间诊断的71例CBF-AML病例.
- 数据收集包括患者人口统计,遗传突变,治疗方案和生存数据.
主要成果:
- 该队列主要是男性 (76%),平均年龄为40岁. 在96%的案件中,De novo AML占比高达96%.
- 更常见的是t(8;21) 转位 (69%). 标准诱导化疗在67%的患者中实现了缓解.
- 平均整体存活期为37个月;对于FLT3-ITD,转位类型,KIT突变或干细胞移植,没有发现显著的生存差异,尽管60岁以下的患者有更好的结果.
结论:
- CBF-AML表现出显著的异质性,挑战了传统的预后标志物.
- 需要重新评估风险分层,优化治疗,实施欧洲白血病网络 (ELN) 的指导方针,并进行持续的分子监测.
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Bone Marrow Sampling and Transplants
275
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
275
Cancers Originate from Somatic Mutations in a Single Cell
11.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.4K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


